IDEAGEN BCG MATRIX TEMPLATE RESEARCH B_114 6M (48% of $89M) of

6M (48% of $89M) of its 2025 engineering spend to AI/ML R&D

Emphasis on patient portal and telehealth capabilities

Expansion into APAC and presence in the US and South Korea are mentioned

Partnerships with financial influencers drove about 15% of new sign-ups

Galapagos now primarily relies on royalties and earn-outs from Jyseleca sales in Europe

IDEAGEN BCG MATRIX TEMPLATE RESEARCH B_114 6M (48% of $89M) ofVisual. Strategic. Downloadable. Ideagen's BCG Matrix snapshot shows a firm navigating a mixed growth market with distinct pockets of strength and underperformers; understanding which products are Stars or Cash Cows and which are Dogs or Question Marks is essential to smart capital allocation and product strategy. Purchase the full BCG Matrix for quadrant level placements, clear strategic moves, and data backed recommendations you can act on